Cita APA

Huber, A., Allam, A. H., Dijkstra, C., Thiem, S., Huynh, J., Poh, A. R., . . . Eissmann, M. F. (2024). Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines.

Citación estilo Chicago

Huber, Anne, et al. Mutant TP53 Switches Therapeutic Vulnerability During Gastric Cancer Progression Within Interleukin-6 Family Cytokines. 2024.

Cita MLA

Huber, Anne, et al. Mutant TP53 Switches Therapeutic Vulnerability During Gastric Cancer Progression Within Interleukin-6 Family Cytokines. 2024.